Sign In
Buy HSDT
$1.51
-0.120 (-7.36%)
At Close: Jun 23, 2026
Zacks Investment Research Downgrades Helius Medical Technologies (OTCMKTS:HSDT) to Hold
01:30am, Wednesday, 15'th Jul 2020
Helius Medical Technologies (OTCMKTS:HSDT) was downgraded by Zacks Investment Research from a “buy” rating to a “hold” rating in a note issued to investors on Wednesday, Zacks.com reports. Acc
Helius Medical Technologies Announces the Dismissal of the Shareholder Class Action Lawsuit
11:05am, Tuesday, 14'th Jul 2020
NEWTOWN, Pa., July 14, 2020 (GLOBE NEWSWIRE) -- Helius Medical Technologies, Inc. (NASDAQ:HSDT) (TSX:HSM) (“Helius” or the “Company”), announced the dismissal of a putative shareholder class a
Oppenheimer Assigns a Buy Rating on Tandem Diabetes Care (TNDM) - Markets
04:56pm, Tuesday, 30'th Jun 2020
Oppenheimer analyst Steven Lichtman assigned a Buy rating to Tandem Diabetes Care (TNDM – Research Report) today and set a
There’s a lot to be optimistic about in the Healthcare sector as 2 analysts just weighed in on Heron Therapeutics
NEW YORK, June 15, 2020 -- Fields Kupka & Shukurov LLP is investigating potential breach of fiduciary duty claims involving the board of directors of Helius Medical.
Hedge Funds Are Nibbling On Helius Medical Technologies, Inc. (HSDT)
06:49pm, Friday, 05'th Jun 2020
In this article we will take a look at whether hedge funds think Helius Medical Technologies, Inc. (NASDAQ:HSDT) is a good investment right now. We check hedge fund and billionaire investor sentiment
Helius Medical Technologies to Present at the Virtual Summer Summit on June 9th
11:05am, Friday, 05'th Jun 2020
A live audio webcast of the presentation will be provided under the ‘Events’ section of the Helius Medical Technologies investor relations website at https://heliusmedical.com/index.php/investor-r
47 Public Companies to present at the Summer Virtual Investor Summit on June 9th-12th
01:00pm, Wednesday, 03'rd Jun 2020
NEW YORK, NY / ACCESSWIRE / June 3, 2020 / The Virtual Summer Summit will take place on June 9 th -12 th , connecting 47 presenting small and microcap companies with distinguished investors from aroun
“We are extremely pleased to receive this designation for our PoNS device,” said Philippe Deschamps, the Company’s CEO. “We look forward to working with FDA to process our application, with t
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.89%
12:00am, Tuesday, 12'th May 2020
U.S. stocks lower at close of trade; Dow Jones Industrial Average down 1.89%
Helius Medical Technologies, Inc. (HSDT) CEO Phil Deschamps on Q1 2020 Results - Earnings Call Transcript
04:21am, Monday, 11'th May 2020
Helius Medical Technologies, Inc. (NASDAQ:HSDT) Q1 2020 Earnings Conference Call May 7, 2020 17:00 ET Company Participants Phil Deschamps - Chairman, President
Helius Medical Technologies, Inc. Reports First Quarter of Full Year 2020 Financial Results; Updates Full Year 2020 Outlook
08:05pm, Thursday, 07'th May 2020
NEWTOWN, Pa., May 07, 2020 -- Helius Medical Technologies, Inc. (Nasdaq:HSDT) (TSX:HSM) (“Helius” or the “Company”), a neurotech company focused on neurological wellness, today.
The Daily Biotech Pulse: FDA Approves Novartis Lung Cancer Drug, 2-Way Contest Emerging For Tetraphase Pharma, Dexcom To Join S&P 500
12:00am, Thursday, 07'th May 2020
Here's a roundup of top developments in the biotech space over the last 24 hours:
Scaling The Peaks
(Biotech stocks hitting 52-week highs May 6.)
Adverum Biotechnologies Inc...
Before You Buy Helius Medical Technologies, Inc. (NASDAQ:HSDT), Consider Its Volatility
12:55pm, Monday, 04'th May 2020
If you own shares in Helius Medical Technologies, Inc. (NASDAQ:HSDT) then it's worth thinking about how it contributes...
The Week Ahead In Biotech: Smid-Cap Earnings News Flow Picks Up Pace
12:00am, Sunday, 03'rd May 2020
Biotech stocks started last week on a strong note but the upward momentum slowed through the week. The week saw a slew of earnings from big pharma names, including Merck...
